- ERCC1 Single Nucleotide Polymorphism C8092A, but Not Its Expression Is Associated with Survival of Esophageal Squamous Cell Carcinoma Patients from Fujian Province, China
Wan-Hua Chen et al, 2014, PLoS ONE CrossRef - A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer
Qiang Zhang et al, 2014, Cancer Chemotherapy and Pharmacology CrossRef - ERCC1 Expression Does Not Predict Survival and Treatment Response in Advanced Stage Non-Small Cell Lung Cancer Cases Treated with Platinum Based Chemotherapy
Ozer Ozdemir et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef - Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy
HAIJIAO JIANG et al, 2015, Molecular Medicine Reports CrossRef - Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer
Elfriede Bollschweiler et al, 2016, Annals of Surgery CrossRef - PEGylated Graphene Oxide-Mediated Protein Delivery for Cell Function Regulation
He Shen et al, 2012, ACS Applied Materials & Interfaces CrossRef - Customizing chemotherapy in thoracic malignancies based on ERCC1 expression
Jens Benn Sørensen et al, 2013, Lung Cancer Management CrossRef